Cited by 68Metabolism, Diabetes, and CancerMetabolomics and Mass Spectrometry StudiesDiabetes Treatment and Management

Metformin Effect on Nontargeted Metabolite Profiles in Patients With Type 2 Diabetes and in Multiple Murine Tissues

Open access
Adam, Jonathan, Brandmaier, Stefan, Leonhardt, Jörn, Scheerer, Markus F., Mohney, Robert P., Xu, Tao, Bi, Jie, Rotter, Markus +20 more·2016·Diabetes

Abstract

Metformin is the first-line oral medication to increase insulin sensitivity in patients with type 2 diabetes (T2D). Our aim was to investigate the pleiotropic effect of metformin using a nontargeted metabolomics approach. We analyzed 353 metabolites in fasting serum samples of the population-based human KORA (Cooperative Health Research in the Region of Augsburg) follow-up survey 4 cohort. To compare T2D patients treated with metformin (mt-T2D, n = 74) and those without antidiabetes medication (ndt-T2D, n = 115), we used multivariable linear regression models in a cross-sectional study. We applied a generalized estimating equation to confirm the initial findings in longitudinal samples of 683 KORA participants. In a translational approach, we used murine plasma, liver, skeletal muscle, and epididymal adipose tissue samples from metformin-treated db/db mice to further corroborate our findings from the human study. We identified two metabolites significantly (P < 1.42E-04) associated with metformin treatment. Citrulline showed lower relative concentrations and an unknown metabolite X-21365 showed higher relative concentrations in human serum when comparing mt-T2D with ndt-T2D. Citrulline was confirmed to be significantly (P < 2.96E-04) decreased at 7-year follow-up in patients who started metformin treatment. In mice, we validated significantly (P < 4.52E-07) lower citrulline values in plasma, skeletal muscle, and adipose tissue of metformin-treated animals but not in their liver. The lowered values of citrulline we observed by using a nontargeted approach most likely resulted from the pleiotropic effect of metformin on the interlocked urea and nitric oxide cycle. The translational data derived from multiple murine tissues corroborated and complemented the findings from the human cohort.

Integrity signals

Registry

Crossref · 10.2337/db16-0512

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The metabolomics data link lowering of citrulline to an increase in NO generation from arginine and improved eNOS activity, supporting that metformin protects the cardiovascular system via promoting NO generation.

    “The metabolomics data can links the lowering of citrulline to the increase in NO generation from arginine and improved eNOS activity, thus providing support to the literature that metformin protects the cardiovascular system via promoting the generation of NO (175).”
  • Data from a metabolomics analysis of T2DM patients treated with metformin indicated that levels of the amino acid citrulline were lower than controls, with comparable data from tissues from the db/db mouse model.

    “Data from a metabolomics analysis of T2DM patients treated with metformin has indicated that levels of the amino acid citrulline were lower than controls with comparable data from tissues from the db/db mouse model of T2DM and obesity.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Adam, J., Brandmaier, S., Leonhardt, J., Scheerer, M. F., Mohney, R. P., Xu, T., Bi, J., Rotter, M., Troll, M., Chi, S., Heier, M., Herder, C., Rathmann, W., Giani, G., Adamski, J., Illig, T., Strauch, K., Li, Y., Gieger, C., Peters, A., Suhre, K., Ankerst, D., Meitinger, T., Hrabĕ de Angelis, M., Roden, M., Neschen, S., Kastenmüller, G., & Wang-Sattler, R.
Affiliations
  • Helmholtz Munich (DE)
  • Metabolon (United States) (US)
  • Chinese Academy of Sciences (CN)
  • Deutsches Diabetes-Zentrum e.V. (DE)
  • Medizinische Hochschule Hannover (DE)
  • Harvard University (US)
  • Technical University of Munich (DE)
  • Institute of Experimental Genetics, Helmholtz Zentrum München, Neuherberg, Germany
  • ShanghaiTech University (CN)
  • Research Unit of Molecular Epidemiology, Helmholtz Zentrum München, Neuherberg, Germany
Venue
Diabetes
Published
2016-09-12
Volume
65
Issue
12
Pages
3776-3785
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2520708667
Cited by
68
References
51
Citations by year
2026: 4 · 2025: 4 · 2024: 9 · 2023: 9 · 2022: 7 · 2021: 11 · 2020: 8 · 2019: 4 · 2018: 6 · 2017: 4 · 2016: 2
FWCI
2.77
Type
journal article
Language
en
Open access
Locations
  • Diabetes (publishedVersion)
  • PubMed (publishedVersion)
  • mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
  • mediaTUM (Technical University of Munich) (submittedVersion, other-oa)
  • Site cant be reached (submittedVersion)
  • PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
Funders
  • Bundesministerium für Bildung und Forschung
  • Seventh Framework Programme (HEALTH-2009-2.2.1-3/242114 (Project OPTiMiSE), HEALTH-2013-2.4.2-1/602936 (Project CarTarDis))
  • Bundesministerium für Gesundheit
  • Ministry of Innovation, Science and Research of the State of North Rhine-Westphalia
  • Deutsche Forschungsgemeinschaft (DFG; RA 459/3-1)
  • Weill Cornell Medical College
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
metformin, type 2 diabetes, untargeted metabolomics, citrulline, pleiotropic drug effects, urea cycle, db/db mice, skeletal muscle, adipose tissue, liver, serum metabolites, KORA cohort
MeSH terms
Adipose Tissue, Animals, Citrulline, Diabetes Mellitus, Type 2, Fasting, Humans, Hypoglycemic Agents, Insulin Resistance, Longitudinal Studies, Male, Metformin, Models, Biological, Muscle, Skeletal, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review